Search

MedicalResearch.com Interview with: Ekta Agarwal, Ph.D. Postdoctoral fellow in the lab of Dario Altieri, M.D. Wistar president and CEO ,Director of the Institute’s Cancer Center Robert & Penny Fox Distinguished Professor and co-first author on the study. MedicalResearch.com: What is the background for this study?   Response: Mitochondrial reprogramming is...

In carefully selected patients with diabetes and stable coronary artery disease who have a history of previous coronary stenting and have presumably tolerated DAPT in the past without bleeding complications, the combination of ticagrelor plus low-dose aspirin should be considered.